Last updated on 16 December 2024
The HBV Cure working group aims to contribute actively to the identification of new therapeutic targets and antiviral molecules for a functional cure of the HBV virus.
One of the priorities is also to support basic research with translational and clinical research.
Fabien Zoulim
Inserm U1052, CHU Lyon – Lyon Cancer Research Centre
Chloé Duquesnay (Coordinatrice des instances scientifiques)
Tounès Saïdi (Cheffe de projet)